Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial.

E E Wang, R Milner, U Allen, H Maj

Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

A randomised double blind trial was conducted to determine the efficacy of inhaled bronchodilators, salbutamol and ipratropium bromide, compared with placebo in the treatment of bronchiolitis. Patients, who were 2 months to 2 years of age and without underlying cardiac or pulmonary disease, received drug 1 (salbutamol or saline placebo) followed one hour later by drug 2 (ipratropium bromide or placebo). Both agents were administered every four hours. The patients were allocated to one of four groups according to a factorial design. The four groups were similar in demographic characteristics, initial oxygenation, and clinical score. The change in oxygen saturation of recipients of both agents was significantly better than that of recipients of salbutamol alone or ipratropium bromide alone. This change, however, was not statistically different from that of the control group. No difference was observed in the clinical score or hospital duration. Inhaled bronchodilators did not improve the condition of hospitalised mild bronchiolitis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Subcommittee on Diagnosis and Management of Bronch, (2006). Diagnosis and Management of Bronchiolitis. Pediatrics 118: 1774-1793 [Abstract] [Full Text]  
• King, V. J., Viswanathan, M., Bordley, W. C., Jackman, A. M., Sutton, S. F., Lohr, K. N., Carey, T. S. (2004). Pharmacologic Treatment of Bronchiolitis in Infants and Children: A Systematic Review. Arch Pediatr Adolesc Med 158: 127-137 [Abstract] [Full Text]  
• Mallory, M. D., Shay, D. K., Garrett, J., Bordley, W. C. (2003). Bronchiolitis Management Preferences and the Influence of Pulse Oximetry and Respiratory Rate on the Decision to Admit. Pediatrics 111: e45-51 [Abstract] [Full Text]  
• Kotagal, U. R., Robbins, J. M., Kini, N. M., Schoettker, P. J., Atherton, H. D., Kirschbaum, M. S. (2002). Impact of a Bronchiolitis Guideline* : A Multisite Demonstration Project. Chest 121: 1789-1797 [Abstract] [Full Text]  
• Willson, D. F., Horn, S. D., Hendley, J. O., Smout, R., Gassaway, J. (2001). Effect of Practice Variation on Resource Utilization in Infants Hospitalized for Viral Lower Respiratory Illness. Pediatrics 108: 851-855 [Abstract] [Full Text]  
• NUMA, A. H., WILLIAMS, G. D., DAKIN, C. J. (2001). The Effect of Nebulized Epinephrine on Respiratory Mechanics and Gas Exchange in Bronchiolitis. Am. J. Respir. Crit. Care Med. 164: 86-91 [Abstract] [Full Text]  
• Perlstein, P. H., Kotagal, U. R., Bolling, C., Steele, R., Schoettker, P. J., Atherton, H. D., Farrell, M. K. (1999). Evaluation of an Evidence-based Guideline for Bronchiolitis. Pediatrics 104: 1334-1341 [Abstract] [Full Text]  
• Dobson, J. V., Stephens-Groff, S. M., McMahon, S. R., Stemmler, M. M., Brallier, S. L., Bay, C. (1998). The Use of Albuterol in Hospitalized Infants With Bronchiolitis. Pediatrics 101: 361-368 [Abstract] [Full Text]  
• Flores, G., Horwitz, R. I. (1997). Efficacy of beta 2-Agonists in Bronchiolitis: A Reappraisal and Meta-analysis. Pediatrics 100: 233-239 [Abstract] [Full Text]  
• Kellner, J. D., Ohlsson, A., Gadomski, A. M., Wang, E. E. L. (1996). Efficacy of Bronchodilator Therapy in Bronchiolitis: A Meta-analysis. Arch Pediatr Adolesc Med 150: 1166-1172 [Abstract]  
• Reijonen, T., Korppi, M., Pitkakangas, S., Tenhola, S., Remes, K. (1995). The Clinical Efficacy of Nebulized Racemic Epinephrine and Albuterol in Acute Bronchiolitis. Arch Pediatr Adolesc Med 149: 686-692 [Abstract]  
• Isaacs, D. (1995). Bronchiolitis. BMJ 310: 4-5 [Full Text]  
• Hickey, R. W., Gochman, R. F., Chande, V., Davis, H. W. (1994). Albuterol Delivered via Metered-Dose Inhaler With Spacer for Outpatient Treatment of Young Children With Wheezing. Arch Pediatr Adolesc Med 148: 189-194 [Abstract]